Certificate Lookup
CAREERS CONTACT
Search
Your
Cart
Menu

  • webinars

Webinars

WEBINAR: Engineered Heart Tissues for Evaluating Safety & Efficacy of Gene Therapies

December 4, 2024 | 10:00 AM CST

MyoPod® Engineered Heart Tissues using iCell® Cardiomyocytes are physiologically relevant in vitro models for evaluating safety and efficacy of vector-based gene therapies. Wednesday, December 4th, 2024  •  10:00 AM CST MyoPod® Engineered Heart Tissues (EHT) are fully functional, mature, and machine-readable cardiac tissues generated by seeding human iPSC derived cardiomyocytes into decellularized myocardial matrix. The EHTs [...]
Find out More

WEBINAR: Scientific Shorts: Neuroscience 2024 Poster Recap with New iPSC-derived Cell Types and Applications

October 23, 2024 | 11:00 AM CST
During this webinar, we reviewed the exciting scientific research FCDI presented at Neuroscience 2024 as four 10-minute talks. Key topics include: Optimization of cytokine release assays for iCell® Microglia and the role of healthy microglia and TREM2 variants in neuroprotection and neurodegeneration. Assays to evaluate iCell Sensory Neurons function and techniques to investigate immune-mediated neuropathic [...]
Find out More

WEBINAR: iPSCs and Neurodegeneration: Establishing relevant cellular models and assays for advancing drug discovery

September 17, 2024 | 9:00 AM CST
Neurodegenerative diseases continue to be a challenge in the development of effective drug treatments by the pharmaceutical industry. This is due to the diversity of genetics and environmental factors that impact disease risk as well as the difficulty in modeling the complex anatomy and interplay of brain cells in vitro. Human induced pluripotent stem cell [...]
Find out More
Upcoming Webinars

WEBINAR: Engineered Heart Tissues for Evaluating Safety & Efficacy of Gene Therapies

December 4, 2024 | 10:00 AM CST

MyoPod® Engineered Heart Tissues using iCell® Cardiomyocytes are physiologically relevant in vitro models for evaluating safety and efficacy of vector-based gene therapies. Wednesday, December 4th, 2024  •  10:00 AM CST MyoPod® Engineered Heart Tissues (EHT) are fully functional, mature, and machine-readable cardiac tissues generated by seeding human iPSC derived cardiomyocytes into decellularized myocardial matrix. The EHTs [...]
Find out More
Past Webinars

WEBINAR: Scientific Shorts: Neuroscience 2024 Poster Recap with New iPSC-derived Cell Types and Applications

October 23, 2024 | 11:00 AM CST
During this webinar, we reviewed the exciting scientific research FCDI presented at Neuroscience 2024 as four 10-minute talks. Key topics include: Optimization of cytokine release assays for iCell® Microglia and the role of healthy microglia and TREM2 variants in neuroprotection and neurodegeneration. Assays to evaluate iCell Sensory Neurons function and techniques to investigate immune-mediated neuropathic [...]
Find out More

WEBINAR: iPSCs and Neurodegeneration: Establishing relevant cellular models and assays for advancing drug discovery

September 17, 2024 | 9:00 AM CST
Neurodegenerative diseases continue to be a challenge in the development of effective drug treatments by the pharmaceutical industry. This is due to the diversity of genetics and environmental factors that impact disease risk as well as the difficulty in modeling the complex anatomy and interplay of brain cells in vitro. Human induced pluripotent stem cell [...]
Find out More